PetMed Express vs Laird Superfood
처방약과 반려동물 관리 제품을 판매하는 온라인 약국 vs 웰니스를 위한 식물성 커피 믹스와 크리머. 9월 2026에 내 포트폴리오에 더 잘 맞는 종목은 무엇일까요? 아래에서 쉽게 설명합니다.
PetMed Express built its business delivering prescription and non-prescription pet medications by mail before the pet e-commerce market became brutally competitive, while Laird Superfood sells mushroom-infused coffee creamers and functional foods to health-conscious consumers through DTC and retail channels. Both are small-cap consumer companies trying to hold onto their niche as larger, better-capitalized competitors crowd in. The PetMed Express vs Laird Superfood comparison examines customer retention economics, gross margin trends, and which brand has a defensible enough position to survive the competitive pressure.
PetMed Express built its business delivering prescription and non-prescription pet medications by mail before the pet e-commerce market became brutally competitive, while Laird Superfood sells mushroo...
투자 분석
PetMed Express
PETS
장점
- PetMed Express maintains a focused business model centred on pet medications and supplies, serving a stable and growing pet care market.
- The company has a low beta, indicating less volatility compared to the broader market, which may appeal to risk-averse investors.
- Recent board appointments and management changes suggest efforts to strengthen governance and strategic direction.
고려 사항
- PetMed Express has reported declining revenues and net losses over the past year, reflecting ongoing profitability challenges.
- Analyst consensus is predominantly negative, with multiple sell ratings and limited upside potential forecast for the next twelve months.
- The stock trades at a low valuation with negative earnings, raising concerns about sustainable recovery and future growth prospects.
장점
- Laird Superfood has diversified its product portfolio across plant-based foods and beverages, tapping into the expanding health and wellness trend.
- The company has demonstrated operational improvements, including cost reductions and margin enhancements in recent quarters.
- Laird Superfood maintains a relatively small market capitalisation, offering potential for growth if it captures increased market share.
고려 사항
- Laird Superfood continues to face intense competition from larger, well-funded brands in the plant-based and functional food sectors.
- The company has experienced fluctuating revenues and inconsistent profitability, indicating vulnerability to market and consumer shifts.
- Limited analyst coverage and lower trading liquidity may increase investment risk and reduce price transparency for investors.
Nemo에서 PETS 또는 LSF 매수하기
수수료 무료
주식, ETF 등을 수수료 없이 거래하세요. 수익을 더 많이 지키세요.
신뢰할 수 있는 규제 기관 인가
2015년부터 Exinity Group의 일원으로, 전 세계 100만 명 이상의 고객에게 서비스를 제공합니다.
현금 예치금 6% 이자
투자하지 않은 현금에 연 6%(AER) 이자를 매일 지급합니다.
